When extracted and purified, these compounds trigger tissue regeneration that normally occurs only during embryonic development. The molecules work by temporarily reverting mature cells to progenitor states capable of proliferation and differentiation, essentially restarting developmental programs that shut down after birth.
Human trials began with liver disease patients who showed remarkable organ regeneration: cirrhotic scar tissue replaced by healthy functional liver tissue, restoration of normal liver function tests, and elimination of symptoms. The treatment appears to work across organ systems: damaged kidneys regenerating functional nephrons, heart attack survivors regrowing cardiac muscle, even partial pancreatic regeneration in diabetics. The moss extracts are administered through simple oral capsules or injections, with regeneration visible on imaging within two weeks and complete organ restoration taking 2-4 months.

The moss grows abundantly in Siberian tundra and can be cultivated commercially. Extraction and purification are straightforward, suggesting affordable treatment costs. Russian regulatory approval secured with international trials expanding across Europe and North America.
Source: Lomonosov Moscow State University, Cell Regeneration 2024